Clinical Studies in Diagnostics and Management of Clostridioides difficile (CDI) Infection

In this 2-hour live virtual symposia, expert faculty will deliver foundational didactic presentations on the epidemiology and diagnostic strategies for CDI, effective and durable treatment strategies for initial CDI episodes, and management strategies for recurrent CDI (rCDI). Following the didactic presentations, faculty will have substantial panel discussions of key patient cases and questions.


Initial didactic introduction (5 minutes)

CDI epidemiology and diagnostic testing strategies, including interactive patient cases (30 minutes)

Key data on therapeutic options for initial CDI episodes with patient cases that reflect common scenarios (30 minutes)

The latest data on therapeutic options for recurrent CDI episodes that include relevant patient cases (40 minutes)

Attendee questions answered by the experts (15 minutes)


Date / Time
Event Details


Program Director
Sahil Khanna, MBBS, MS

Professor of Medicine 
Division of Gastroenterology and Hepatology
Mayo Clinic
Rochester, Minnesota

Teena Chopra, MD, MPH

Professor, Infectious Diseases
Wayne State University
Corporate Medical Director
Infection Prevention
Hospital Epidemiology
Detroit Medical Center
Detroit, Michigan

Paul Feuerstadt, MD, FACG, AGAF

Assistant Clinical Professor of Medicine
Attending Gastroenterologist

Department of Gastroenterology
Yale University School of Medicine
PACT-Gastroenterology Center
Hamden, Connecticut

Kevin Garey, PharmD, MS

Professor and Chair
Department of Pharmacy Practice and Translational Research
University of Houston College of Pharmacy
Houston, Texas

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners regarding strategies for diagnosis and management of Clostridioides difficile infections.

Target Audience
This program is intended for physicians, nurses, pharmacists, and other healthcare professionals who care for patients with Clostridioides difficile infections.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Summarize epidemiology and classification of C difficile infections including effective diagnostic strategies and special populations at risk for recurrent C difficile infections.
  • Compare treatment options for initial C difficile infections incorporating the latest guideline-based recommendations.
  • Contrast new data and recommendations on CDI therapeutic agents for treatment and prevention of recurrence of C difficile infections.


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2.0 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education. UAN: JA4008176-0000-22-030-L01-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.